Literature DB >> 9950657

Poor response to activated protein C as a prominent risk predictor of advanced atherosclerosis and arterial disease.

S Kiechl1, A Muigg, P Santer, M Mitterer, G Egger, M Oberhollenzer, F Oberhollenzer, A Mayr, A Gasperi, W Poewe, J Willeit.   

Abstract

BACKGROUND: The potential role of activated protein C (APC) resistance in arterial thrombosis and disease is a matter of ongoing controversy. METHODS AND
RESULTS: In the present population-based survey, a random sample of 826 men and women underwent high-resolution duplex ultrasound scanning of the carotid and femoral arteries. Response to APC was expressed in APC ratios. Subjects were tested for the factor V Leiden mutation. The risk of carotid stenosis increased gradually with decreasing response to APC (adjusted OR [95% CI] for a 1-U decrease of response to APC, 1.6 [1. 2 to 2.2]), as did the risk of femoral artery stenosis (1.7 [1.3 to 2.3]) and prevalent cardiovascular disease (1.4 [1.1 to 2.0]). The association between low APC ratio and atherosclerotic vascular disease applied equally to subjects with the factor V Leiden mutation and those without. Our study identified various nongenetic determinants of poor response to APC in the general population, including behavioral, hormonal, and environmental factors.
CONCLUSIONS: The present study revealed an independent and gradual association between low response to APC and both advanced atherosclerosis (stenosis) and arterial disease. Resistance to APC due to factor V Leiden mutation was only one facet of this relationship.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9950657     DOI: 10.1161/01.cir.99.5.614

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  5 in total

Review 1.  The antiphospholipid syndrome and atherosclerosis: clue to pathogenesis.

Authors:  Joan T Merrill
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

2.  Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy.

Authors:  Karen C Johnson; Aaron K Aragaki; Rebecca Jackson; Alex Reiner; Per Morten Sandset; Jan Rosing; Anders E A Dahm; Frits Rosendaal; JoAnn E Manson; Lisa W Martin; Simin Liu; Lewis H Kuller; Mary Cushman; Jacques E Rossouw
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-12-17       Impact factor: 8.311

3.  The hypercoagulable profile of patients with stent thrombosis.

Authors:  R Loeffen; T C Godschalk; R van Oerle; H M H Spronk; C M Hackeng; J M ten Berg; H ten Cate
Journal:  Heart       Date:  2015-05-21       Impact factor: 5.994

Review 4.  The Cardioprotective Signaling Activity of Activated Protein C in Heart Failure and Ischemic Heart Diseases.

Authors:  Di Ren; Hemant Giri; Ji Li; Alireza R Rezaie
Journal:  Int J Mol Sci       Date:  2019-04-10       Impact factor: 5.923

5.  Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis--results from a large population-based study.

Authors:  Qingzhong Xiao; Stefan Kiechl; Seema Patel; Friedrich Oberhollenzer; Siegfried Weger; Agnes Mayr; Bernhard Metzler; Markus Reindl; Yanhua Hu; Johann Willeit; Qingbo Xu
Journal:  PLoS One       Date:  2007-10-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.